Harty J T, Bevan M J
Howard Hughes Medical Institute, University of Washington, Seattle 98195.
J Exp Med. 1992 Jun 1;175(6):1531-8. doi: 10.1084/jem.175.6.1531.
Class I major histocompatibility complex (MHC)-restricted CD8+ T cells have been demonstrated to be effective mediators of both acquired and adoptive immunity to the intracellular bacterium Listeria monocytogenes. We have recently determined that L. monocytogenes-infected H-2d mice recognize a nonamer peptide, residues 91-99, of the secreted protein listeriolysin O (LLO), in a H-2Kd-restricted fashion. In this report we have generated CD8+ T cell lines with specificity for LLO 91-99 in the context of H-2Kd by in vitro stimulation with P815 (H-2d) cells transfected with LLO. These CD8+ lines have been generated from immune donors after sublethal infection with L. monocytogenes, or after in vivo immunization with syngeneic spleen cells coated with synthetic LLO 91-99 peptide. LLO-specific CD8+ T cells derived from either protocol were capable of significant protection against L. monocytogenes infection. The in vivo protection by these CD8+ T cell lines has been shown to be solely due to recognition of LLO 91-99 in the context of H-2Kd. These studies demonstrate that CD8+ T cell immunity to a single, naturally produced peptide epitope has the potential for significant protection in a bacterial infection. Thus, the allele-specific motif approach to epitope prediction has identified a naturally produced bacterial epitope with biological relevance.
I类主要组织相容性复合体(MHC)限制的CD8 + T细胞已被证明是对细胞内细菌单核细胞增生李斯特菌获得性免疫和过继性免疫的有效介质。我们最近确定,单核细胞增生李斯特菌感染的H-2d小鼠以H-2Kd限制的方式识别分泌蛋白李斯特菌溶素O(LLO)的九聚体肽,第91 - 99位氨基酸残基。在本报告中,我们通过用转染了LLO的P815(H-2d)细胞进行体外刺激,产生了在H-2Kd背景下对LLO 91 - 99具有特异性的CD8 + T细胞系。这些CD8 +细胞系是从经亚致死剂量单核细胞增生李斯特菌感染后的免疫供体,或用包被有合成LLO 91 - 99肽的同基因脾细胞进行体内免疫后的供体中产生的。源自这两种方案的LLO特异性CD8 + T细胞都能够对单核细胞增生李斯特菌感染提供显著保护。这些CD8 + T细胞系在体内的保护作用已被证明完全是由于在H-2Kd背景下对LLO 91 - 99的识别。这些研究表明,针对单个天然产生的肽表位的CD8 + T细胞免疫在细菌感染中具有显著保护的潜力。因此,表位预测的等位基因特异性基序方法已经鉴定出一个具有生物学相关性的天然产生的细菌表位。